Articles liés
vaccin personnalisé à ARNm contre le cancer
Moderna's individualized mRNA therapeutic vaccine against cancer, reported to reduce recurrence or death risk by 42% in advanced melanoma.
Articles liés
Moderna's individualized mRNA therapeutic vaccine against cancer, reported to reduce recurrence or death risk by 42% in advanced melanoma.